Filing Details
- Accession Number:
- 0000899243-21-025738
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-24 16:16:10
- Reporting Period:
- 2021-06-22
- Accepted Time:
- 2021-06-24 16:16:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1840904 | Atai Life Sciences N.v. | ATAI | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1845711 | Ltd. Group Investment Apeiron | 66 &Amp; 67, Beatrice, Amery Street Sliema O1 SLM1707 | No | No | Yes | No | |
| 1860536 | Presight Ii, Lp | 66 &Amp; 67, Beatrice, Amery Street Sliema O1 SLM1707 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2021-06-22 | 700,000 | $15.00 | 20,185,200 | No | 4 | P | Indirect | By Apeiron Investment Group Ltd. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Apeiron Investment Group Ltd. |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares | 1,187,104 | Indirect | By Presight II, L.P. |
Footnotes
- Apeiron Investment Group Ltd. is the co-managing member of Presight Capital Management I, LLC, which is the general partner of Presight II, L.P. Therefore, Apeiron Investment Group Ltd. may be deemed to share beneficial ownership of the Common Shares held by Presight II, L.P. Apeiron Investment Group Ltd. is owned and controlled by Christian Angermayer. Mr. Angermayer may be deemed to have beneficial ownership over the shares held by Apeiron Investment Group Ltd. and Presight II, L.P.
Billionaire Hedge Funds
